The benefits and risks of new therapies for type 2 diabetes.
Asche
Carl V
CV
Pharmacotherapy Outcomes Research Center, University of Utah College of Pharmacy, Salt Lake City, UT 84108, USA. carl.asche@pharm.utah.edu
Nelson
Richard E
RE
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D018570:Risk Assessment; D014481:United States / Q000453:epidemiology
D001786:Blood Glucose; D007004:Hypoglycemic Agents